COMPANY PROFILE

Indigo Biosystems

Explore full profile

Laboratories improve their efficiency and business performance

Carmel, United StatesFounded 2006Biotech & Life Sciences

Valuation $50–100M Last recorded · 2014

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Indigo Biosystems

Indigo BioAutomation specializes in providing automated data analysis solutions tailored for laboratories utilizing chromatography and mass spectrometry. The company serves clinical, toxicology, and reference laboratories by offering ASCENT, a platform that automates the processing, reviewing, and reporting of quantitative data. Operating in the healthcare and scientific research markets, Indigo BioAutomation's business model revolves around delivering cloud-based tools that eliminate the need for human inspection of laboratory data, thereby enhancing productivity and efficiency. Revenue is generated through the provision of these advanced analytical tools, which are trusted by leading laboratories to improve technical efficiency and business performance. The company's mission is to improve human health by interpreting molecular measurements through a global, real-time platform.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2006
Headquarters: Carmel, United States
Employees: 42
Open positions: None listed
Dealroom signal: 66.6/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, UKSU, science-based
Technology: Artificial Intelligence
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Jun 2014	$8.5M	$34M	Undisclosed	—
EARLY VC✓Equity / VC	Jan 2011	$1.8M	$7.2M	Undisclosed	—

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Indigo Biosystems website traffic

Latest recorded traffic for Indigo Biosystems is 1.3K monthly website visits, down 60.6% over the last three months. Indigo Biosystems's team declined 4.5% over the past year.

Latest monthly visits1.3K 3-month web change-60.6% 1-year team growth-4.5%

Monthly website visitsApr 2016–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CHChemifyDigitizing chemistry by developing technology to convert chemical code into molecules and vice versa	Glasgow, United Kingdom	Operational	196	$104M	$200M
NTNucleome TherapeuticsDecoding the dark matter of the human genome to discover first-in-class precision medicine	Oxford, United Kingdom	Operational
RBRosa BiotechAI-driven biosensing and diagnostics company providing outcome-focused biosensing for early disease diagnosis and for use in industrial biotechnology	Bristol, United Kingdom	Operational
SBScenic BiotechGenetic modifier therapies for rare inherited diseases	Amsterdam, Netherlands	Operational
CDC4X DiscoveryC4X Discovery - building the world's most productive drug discovery engine	Manchester, United Kingdom	Operational
SBSilvia BioCellular analysis and media for biomanufacturing optimization.	Sheffield, United Kingdom	Operational
MLMitotype Precision LabsHigh-throughput mitochondrial assays for drug discovery	Sheffield, United Kingdom	Operational
DTDraig TherapeuticsTargeted neuromodulators for major neuropsychiatric disorders treatment	Cardiff, United Kingdom	Operational